Ander C. Krupa
Known title: General Counsel & SecCIK: 0002077449
Associated companies
Transaction History
| ALB | ▲ Buy | Grant | 1,796 | $0 | 3/2/2026 | View on chart |
| ALB | ▲ Buy | Grant | 173 | $32K | 2/26/2026 | View on chart |
| ALB | ▼ Sell | Tax Withholding | 80 | $15K | 2/26/2026 | View on chart |
| ALB | ▼ Sell | Tax Withholding | 188 | $35K | 2/24/2026 | View on chart |
| ALB | ▼ Sell | Open Market | 172 | $18K | 10/24/2025 | View on chart |
| ALB | ▼ Sell | Open Market | 116 | $11K | 10/9/2025 | View on chart |
| ALB | ▲ Buy | Grant | 7,430 | $0 | 8/6/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Albemarle Faces Q3 Earnings Test Amid Mixed Analyst Views
Albemarle is set to report third-quarter earnings on November 4, 2026, a key date for the battery materials sector. While some analysts note improving fundamentals, Mizuho recently lowered its price target to $130 and maintained a Neutral rating. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite recent positive news about supply chain resilience.
Albemarle Faces Q3 Earnings Test Amid Mixed Analyst Views. Albemarle is set to report third-quarter earnings on November 4, 2026, a key date for the battery materials sector. While some analysts note improving fundamentals, Mizuho recently lowered its price target to $130 and maintained a Neutral rating. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite recent positive news about supply chain resilience.